Enovis (ENOV) Net Income towards Common Stockholders Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Enovis | 1.25 Bn | 1.22 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -14.89% |
| Dec 31, 2025 | 49.82% |
| Oct 3, 2025 | -14.90% |
| Jul 4, 2025 | 59.44% |
| Apr 4, 2025 | -15.19% |
| Dec 31, 2024 | 14.92% |
| Sep 27, 2024 | -26.52% |
| Jun 28, 2024 | 82.93% |
| Dec 31, 2023 | 14.87% |
| Sep 29, 2023 | -2.18% |
| Jun 30, 2023 | 22.79% |
| Mar 31, 2023 | -15.30% |
| Dec 31, 2022 | 21.63% |
| Sep 30, 2022 | -17.64% |
| Jul 1, 2022 | 25.69% |
| Apr 1, 2022 | 15.73% |
| Dec 31, 2021 | -17.80% |
| Oct 1, 2021 | -1.57% |
| Jul 2, 2021 | -6.35% |
| Apr 2, 2021 | -3.35% |
| Dec 31, 2020 | -25.99% |
| Oct 2, 2020 | -6.09% |
| Jul 3, 2020 | -16.65% |
| Apr 3, 2020 | -38.77% |
| Dec 31, 2019 | -26.37% |
| Sep 27, 2019 | -32.25% |
| Jun 28, 2019 | -34.77% |
| Mar 29, 2019 | -32.55% |
| Dec 31, 2018 | -51.98% |
| Sep 28, 2018 | -18.12% |
| Jun 29, 2018 | -16.15% |
| Mar 30, 2018 | -18.16% |
| Dec 31, 2017 | -29.75% |
| Sep 29, 2017 | -12.34% |
| Jun 30, 2017 | -95.31% |
| Mar 31, 2017 | -12.61% |
| Dec 31, 2016 | 34.18% |
| Sep 30, 2016 | 49.95% |
| Jul 1, 2016 | 30.78% |
| Apr 1, 2016 | 28.10% |
| Dec 31, 2015 | 38.57% |
| Sep 25, 2015 | 25.70% |
| Jun 26, 2015 | 91.04% |